|
HY-100216-10mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-100216-100mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-100216-200mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-100216-5mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-100216-50mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-100216-500mg
|
MedChemexpress LLC
|
SPDP [CAS 68181-17-9]
|
|
|
|
|
HY-101070-1mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101070-10mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101070-100mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101070-25mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101070-5mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101070-50mg
|
MedChemexpress LLC
|
SMCC-DM1 [CAS 1228105-51-8]
|
|
Cancer-programmed cell death
|
|
|
HY-101157-10mg
|
MedChemexpress LLC
|
Propargyl-PEG5-acid [CAS 1245823-51-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101157-100mg
|
MedChemexpress LLC
|
Propargyl-PEG5-acid [CAS 1245823-51-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101157-25mg
|
MedChemexpress LLC
|
Propargyl-PEG5-acid [CAS 1245823-51-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101157-5mg
|
MedChemexpress LLC
|
Propargyl-PEG5-acid [CAS 1245823-51-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101157-50mg
|
MedChemexpress LLC
|
Propargyl-PEG5-acid [CAS 1245823-51-1]
|
|
Cancer-programmed cell death
|
|
|
HY-103347-5mg
|
MedChemexpress LLC
|
M50054 [CAS 54135-60-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-103613-1g
|
MedChemexpress LLC
|
Thalidomide-O-amido-C4-NH2 (TFA) [CAS 1799711-25-3]
|
|
|
|
|
HY-103613-100mg
|
MedChemexpress LLC
|
Thalidomide-O-amido-C4-NH2 (TFA) [CAS 1799711-25-3]
|
|
|
|
|
HY-103613-2g
|
MedChemexpress LLC
|
Thalidomide-O-amido-C4-NH2 (TFA) [CAS 1799711-25-3]
|
|
|
|
|
HY-103613-500mg
|
MedChemexpress LLC
|
Thalidomide-O-amido-C4-NH2 (TFA) [CAS 1799711-25-3]
|
|
|
|
|
HY-103614-1g
|
MedChemexpress LLC
|
Thalidomide-O-amido-C8-NH2 (TFA) [CAS 1950635-16-1]
|
|
|
|
|
HY-103614-100mg
|
MedChemexpress LLC
|
Thalidomide-O-amido-C8-NH2 (TFA) [CAS 1950635-16-1]
|
|
|
|
|
HY-103614-2g
|
MedChemexpress LLC
|
Thalidomide-O-amido-C8-NH2 (TFA) [CAS 1950635-16-1]
|
|
|
|
